NYSE: OSGOctave Specialty Group Inc Stock
$5.35-0.17 (-3.08%)
Updated Feb 27, 2026
OSG Price
$5.35
Fair Value Price
N/A
Market Cap
$234.39M
52 Week Low
$4.98
52 Week High
$10.38
P/E
-0.34x
P/B
0.28x
P/S
4.05x
PEG
N/A
Dividend Yield
N/A
Revenue
$99.13M
Earnings
-$780.16M
Gross Margin
-8.7%
Operating Margin
-826.68%
Profit Margin
-787%
Debt to Equity
1.19
Operating Cash Flow
$26M
Beta
0.71
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OSG Overview
Ambac Financial Group, Inc., a financial services holding company, provides financial guarantees in the United States, the United Kingdom, Italy, Austria, Australia, France, and Internationally. It offers financial guarantee insurance policies; and credit derivative contracts and interest rate derivative transactions. The company was incorporated in 1991 and is headquartered in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OSG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Insurance
Industry Rating
D
OSG
Ranked#17 of 20
Ranked#17 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $70.11 | C | |
| $7.00 | C | |
| $17.03 | C |
Be the first to know about important OSG news, forecast changes, insider trades & much more!
OSG News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OSG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OSG is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OSG is good value based on its book value relative to its share price (0.28x), compared to the US Insurance - Specialty industry average (1.5x)
P/B vs Industry Valuation
OSG is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OSG due diligence checks available for Premium users.
Valuation
OSG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.34x
Industry
22.06x
Market
37.99x
OSG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.28x
Industry
1.5x
OSG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OSG's financial health
Profit margin
Revenue
$66.6M
Net Income
-$112.6M
Profit Margin
-169.1%
OSG's Earnings (EBIT) of -$819.53M... subscribe to Premium to read more.
Interest Coverage Financials
OSG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.1B
Liabilities
$1.0B
Debt to equity
1.19
OSG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OSG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.3M
Investing
$259.4M
Financing
-$249.3M
OSG's operating cash flow ($26.41M)... subscribe to Premium to read more.
Debt Coverage Financials
OSG vs Specialty Insurance Stocks
Octave Specialty Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.